Values First Advisors’s Transmedics TMDX Stock Holding History

Values First Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$591K	Buy	5,944 +181	+3%	+$23.6K	0.31%	89
2025 Q4	$701K	Sell	5,763 -75	-1%	-$9.41K	0.36%	79
2025 Q3	$655K	Sell	5,838 -288	-5%	-$33.7K	0.35%	79
2025 Q2	$821K	Buy	6,126 +489	+9%	+$53.7K	0.45%	64
2025 Q1	$380K	Sell	5,637 -45	-0.8%	-$3.1K	0.22%	120
2024 Q4	$354K	Sell	5,682 -87	-2%	-$8.1K	0.2%	125
2024 Q3	$906K	Sell	5,769 -3,299	-36%	-$508K	0.49%	56
2024 Q2	$1.37M	Sell	9,068 -693	-7%	-$83.1K	0.82%	41
2024 Q1	$722K	Buy	9,761 +1,096	+13%	+$90.3K	0.42%	71
2023 Q4	$684K	Buy	+8,665	New	+$523K	0.41%	80

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Values First Advisors's TMDX Position: Q1 2026 in Review

Values First Advisors increased its Transmedics (TMDX) stake by 3.1% in Q1 2026, buying an estimated $23.6K and bringing the position to 5,944 shares worth $591K. The position accounts for 0.31% of the portfolio, ranked #89.

Values First Advisors first reported a position in TMDX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.37M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Values First Advisors held 5,944 shares of Transmedics worth $591K as of Q1 2026.
Values First Advisors bought 181 Transmedics shares in Q1 2026, an estimated $23.6K.
Transmedics made up 0.31% of Values First Advisors's portfolio in Q1 2026, its #89 holding.
Values First Advisors first reported a position in Transmedics in Q4 2023 and has held it in 10 quarters since.
Values First Advisors's Transmedics position peaked at $1.37M in Q2 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.